Sectors & IndustriesHealthcareHealthcare Plans
Best Healthcare Plan Stocks to Buy Now (2025)
Top healthcare plan stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best healthcare plan stocks to buy now. Learn More.

Industry: Healthcare Plans
A
Healthcare Plans is Zen Rated A and is the 4th ranked industry out of 145 stock market industries
Learn how the Zen Ratings work
Ticker
Company
Zen Rating
Growth
Market Cap
Revenue
EBITDA
Earnings
EPS
Rev. Y/Y
Rev. 5Y
Earn. Y/Y
Earn. 5Y
Earnings Date
CI
CIGNA GROUP
$88.88B$247.12B$9.14B$3.43B$12.2526.56%9.98%-30.28%-2.04%2025-04-30
CNC
CENTENE CORP
$28.78B$163.07B$6.21B$3.31B$6.335.89%16.92%27.36%14.69%2025-04-24
ELV
ELEVANCE HEALTH INC
$92.46B$177.01B$10.49B$5.98B$25.813.31%11.18%1.69%6.53%
UNH
UNITEDHEALTH GROUP INC
$389.05B$400.28B$27.24B$14.41B$15.647.71%10.57%-35.16%1.46%
CVS
CVS HEALTH CORP
$82.17B$372.81B$9.13B$4.61B$3.674.20%7.74%-43.45%-6.37%2025-04-29
HUM
HUMANA INC
$29.67B$117.76B$3.25B$1.21B$10.0110.70%12.66%-50.17%-13.10%2025-04-22
OSCR
OSCAR HEALTH INC
$2.92B$9.18B$88.62M$25.43M$0.1156.54%79.82%N/AN/A2025-05-05
ALHC
ALIGNMENT HEALTHCARE INC
$3.36B$2.70B-$75.64M-$128.04M-$0.6748.25%28.99%N/AN/A2025-04-30
MOH
MOLINA HEALTHCARE INC
$16.77B$40.65B$1.89B$1.18B$20.5219.31%19.29%8.51%11.61%2025-04-22
CLOV
CLOVER HEALTH INVESTMENTS CORP
$1.70B$1.37B-$41.68M-$43.01M-$0.098.77%24.29%N/AN/A2025-05-05
NEUE
NEUEHEALTH INC
$56.17M$936.66M-$97.74M-$186.33M-$22.65-19.31%27.26%N/AN/A2025-05-02

Healthcare Plan Stocks FAQ

What are the best healthcare plan stocks to buy right now in Apr 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best healthcare plan stocks to buy right now are:

1. Cigna Group (NYSE:CI)


Cigna Group (NYSE:CI) is the #1 top healthcare plan stock out of 11 with a Zen Rating of B. Stocks with a rating of B have had an average return of +19.88% per year. Learn more.

The Component Grade breakdown for Cigna Group (NYSE:CI) is: Value: B, Growth: B, Momentum: C, Sentiment: C, Safety: C, Financials: B, and AI: C.

Cigna Group (NYSE:CI) has a Due Diligence Score of 41, which is equal to the healthcare plan industry average of 41.

CI passed 14 out of 38 due diligence checks and has strong fundamentals. Cigna Group has seen its stock lose -8.04% over the past year, overperforming other healthcare plan stocks by 9 percentage points.

Cigna Group has an average 1 year price target of $372.60, an upside of 14.73% from Cigna Group's current stock price of $324.77.

Cigna Group stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 15 analysts covering Cigna Group, 73.33% have issued a Strong Buy rating, 20% have issued a Buy, 6.67% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Centene (NYSE:CNC)


Centene (NYSE:CNC) is the #2 top healthcare plan stock out of 11 with a Zen Rating of B. Stocks with a rating of B have had an average return of +19.88% per year. Learn more.

The Component Grade breakdown for Centene (NYSE:CNC) is: Value: B, Growth: C, Momentum: C, Sentiment: A, Safety: C, Financials: C, and AI: B.

Centene (NYSE:CNC) has a Due Diligence Score of 50, which is 9 points higher than the healthcare plan industry average of 41.

CNC passed 16 out of 33 due diligence checks and has strong fundamentals. Centene has seen its stock lose -23.25% over the past year, underperforming other healthcare plan stocks by -7 percentage points.

Centene has an average 1 year price target of $79.36, an upside of 36.81% from Centene's current stock price of $58.01.

Centene stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 11 analysts covering Centene, 54.55% have issued a Strong Buy rating, 18.18% have issued a Buy, 27.27% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Elevance Health (NYSE:ELV)


Elevance Health (NYSE:ELV) is the #3 top healthcare plan stock out of 11 with a Zen Rating of B. Stocks with a rating of B have had an average return of +19.88% per year. Learn more.

The Component Grade breakdown for Elevance Health (NYSE:ELV) is: Value: B, Growth: C, Momentum: C, Sentiment: C, Safety: C, Financials: C, and AI: C.

Elevance Health (NYSE:ELV) has a Due Diligence Score of 53, which is 12 points higher than the healthcare plan industry average of 41.

ELV passed 19 out of 38 due diligence checks and has strong fundamentals. Elevance Health has seen its stock lose -23.59% over the past year, underperforming other healthcare plan stocks by -7 percentage points.

Elevance Health has an average 1 year price target of $499.27, an upside of 22.76% from Elevance Health's current stock price of $406.69.

Elevance Health stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 9 analysts covering Elevance Health, 66.67% have issued a Strong Buy rating, 11.11% have issued a Buy, 22.22% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare plan stocks with highest dividends?

Out of 4 healthcare plan stocks that have issued dividends in the past year, the 3 healthcare plan stocks with the highest dividend yields are:

1. Unitedhealth Group (NYSE:UNH)


Unitedhealth Group (NYSE:UNH) has an annual dividend yield of 1.97%, which is the same as the healthcare plan industry average of 1.7%. Unitedhealth Group's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Unitedhealth Group's dividend has shown consistent growth over the last 10 years.

Unitedhealth Group's dividend payout ratio of 52.3% indicates that its dividend yield is sustainable for the long-term.

2. Cigna Group (NYSE:CI)


Cigna Group (NYSE:CI) has an annual dividend yield of 1.76%, which is the same as the healthcare plan industry average of 1.7%. Cigna Group's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Cigna Group's dividend has shown consistent growth over the last 10 years.

Cigna Group's dividend payout ratio of 45.7% indicates that its dividend yield is sustainable for the long-term.

3. Elevance Health (NYSE:ELV)


Elevance Health (NYSE:ELV) has an annual dividend yield of 1.62%, which is the same as the healthcare plan industry average of 1.7%. Elevance Health's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Elevance Health's dividend has shown consistent growth over the last 10 years.

Elevance Health's dividend payout ratio of 25.3% indicates that its dividend yield is sustainable for the long-term.

Why are healthcare plan stocks down?

Healthcare plan stocks were down -4.93% in the last day, and down -13.76% over the last week. Humana was the among the top losers in the healthcare plans industry, dropping -7.02% yesterday.

Shares of health insurance stocks are trading lower in sympathy with UnitedHealth, which reported worse-than-expected Q1 results and cut its FY25 adjusted EPS guidance below estimates on Thursday.

What are the most undervalued healthcare plan stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued healthcare plan stocks right now are:

1. Centene (NYSE:CNC)


Centene (NYSE:CNC) is the most undervalued healthcare plan stock based on its Valuation Rating of B. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Centene has a valuation score of 43, which is 16 points higher than the healthcare plan industry average of 27. It passed 3 out of 7 valuation due diligence checks.

Centene's stock has dropped -23.25% in the past year. It has underperformed other stocks in the healthcare plan industry by -7 percentage points.

2. Elevance Health (NYSE:ELV)


Elevance Health (NYSE:ELV) is the second most undervalued healthcare plan stock based on its Valuation Rating of B. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Elevance Health has a valuation score of 57, which is 30 points higher than the healthcare plan industry average of 27. It passed 4 out of 7 valuation due diligence checks.

Elevance Health's stock has dropped -23.59% in the past year. It has underperformed other stocks in the healthcare plan industry by -7 percentage points.

3. Cigna Group (NYSE:CI)


Cigna Group (NYSE:CI) is the third most undervalued healthcare plan stock based on its Valuation Rating of B. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Cigna Group has a valuation score of 43, which is 16 points higher than the healthcare plan industry average of 27. It passed 3 out of 7 valuation due diligence checks.

Cigna Group's stock has dropped -8.04% in the past year. It has overperformed other stocks in the healthcare plan industry by 9 percentage points.

Are healthcare plan stocks a good buy now?

54.55% of healthcare plan stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare plan stocks to rise by 25.7% over the next year.

0% of healthcare plan stocks have a Zen Rating of A (Strong Buy), 40% of healthcare plan stocks are rated B (Buy), 60% are rated C (Hold), 0% are rated D (Sell), and 0% are rated F (Strong Sell).

What is the average p/e ratio of the healthcare plans industry?

The average P/E ratio of the healthcare plans industry is 23.44x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.